OPRM1 and colitis: For example, selective MOR agonists, DALDA and DAMGO, are shown to improve TNBS-induced colitis, and MOR and DOR knockout mice are found more susceptible to colitis than the wild type (Philippe et al., 2003; Reiss et al., 2016).